Literature DB >> 2813042

Acute cisplatin nephrotoxicity in the rat. Evidence for impaired entry of sodium into proximal tubule cells.

M J Field1, T E Bostrom, F Seow, A Z Györy, D J Cockayne.   

Abstract

The earliest phase of cisplatin nephrotoxicity involves natriuresis due to impaired sodium reabsorption by the proximal tubule. To define the cell mechanism of this transport lesion, electron microprobe X-ray analysis was used to determine changes in the electrolyte composition of proximal tubule cells in kidneys taken from rats treated acutely with cisplatin (1 mg/100 g body weight). Compared to control animals injected with vehicle, cisplatin treated rats developed significant natriuresis, the fractional excretion of sodium rising over sevenfold. In kidneys removed 90 min following cisplatin, sodium concentration in proximal tubule cells was reduced by 4.2 mmol/kg wet weight, or 19%, compared to control values. When allowance was made for cell shrinkage in cisplatin-treated kidneys by deriving the cell content of sodium (mmol/kg dry weight), the reduction was even greater (28%). These data suggest that cisplatin reduces proximal tubule sodium reabsorption by inhibiting the entry of sodium into the cells across the apical membrane.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813042     DOI: 10.1007/bf00582130

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  25 in total

1.  Electron microprobe analysis of proximal tubule cellular Na, Cl and K element concentrations during acute mannitol-saline volume expansion in rats: evidence for inhibition of the Na pump.

Authors:  A Z Györy; F Beck; R Rick; K Thurau
Journal:  Pflugers Arch       Date:  1985-02       Impact factor: 3.657

2.  Energy-dispersive X-ray microanalysis of air-dried microdroplets containing a macromolecular solute.

Authors:  T E Bostrom; A Z Gyory; D C Benson; E Horgan; C E Nockolds; F X Beck; D J Cockayne
Journal:  J Microsc       Date:  1988-03       Impact factor: 1.758

3.  Electron microprobe analysis of intracellular elements in the rat kidney.

Authors:  F Beck; R Bauer; U Bauer; J Mason; A Dörge; R Rick; K Thurau
Journal:  Kidney Int       Date:  1980-06       Impact factor: 10.612

4.  Cisplatin nephrotoxicity in rats: defect in papillary hypertonicity.

Authors:  R Safirstein; P Miller; S Dikman; N Lyman; C Shapiro
Journal:  Am J Physiol       Date:  1981-08

5.  Functional and histopathological changes in dog kidneys after administration of cisplatin.

Authors:  G Daugaard; U Abildgaard; S Larsen; N H Holstein-Rathlou; O Amtorp; H P Olesen; P P Leyssac
Journal:  Ren Physiol       Date:  1987

6.  Acute effect of cisplatin on renal hemodynamics and tubular function in dog kidneys.

Authors:  G Daugaard; U Abildgaard; N H Holstein-Rathlou; P P Leyssac; O Amtorp; T G Dikhoff
Journal:  Ren Physiol       Date:  1986

7.  Mechanism of cisplatin nephrotoxicity.

Authors:  M W Weiner; C Jacobs
Journal:  Fed Proc       Date:  1983-10

8.  Electrolyte composition of renal tubular cells in gentamicin nephrotoxicity.

Authors:  O Matsuda; F X Beck; A Dörge; K Thurau
Journal:  Kidney Int       Date:  1988-06       Impact factor: 10.612

9.  Intracellular electrolyte composition following renal ischemia.

Authors:  J Mason; F Beck; A Dörge; R Rick; K Thurau
Journal:  Kidney Int       Date:  1981-07       Impact factor: 10.612

10.  gamma-Glutamyl transpeptidase excretion in cisplatin-induced acute renal failure.

Authors:  J A Gordon; V H Gattone; A C Schoolwerth
Journal:  Am J Kidney Dis       Date:  1986-07       Impact factor: 8.860

View more
  2 in total

1.  Proximal tubular cell sodium concentration in early diabetic nephropathy assessed by electron microprobe analysis.

Authors:  C A Pollock; M J Field; T E Bostrom; M Dyne; A Z Gyory; D J Cockayne
Journal:  Pflugers Arch       Date:  1991-03       Impact factor: 3.657

2.  Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.

Authors:  C Bokemeyer; L M Fels; T Dunn; W Voigt; J Gaedeke; H J Schmoll; H Stolte; H Lentzen
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.